Your browser doesn't support javascript.
loading
Reproductive risk factors associated with breast cancer in young women by molecular subtype.
Ruddy, Kathryn J; Vierkant, Robert A; Jahan, Nusrat; Higgins, Alexandra; Partridge, Ann; Larson, Nicole; Radisky, Derek C; Couch, Fergus; Olson, Janet; Sherman, Mark E.
Affiliation
  • Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: Ruddy.kathryn@mayo.edu.
  • Vierkant RA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Jahan N; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Higgins A; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Partridge A; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Larson N; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Radisky DC; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
  • Couch F; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Olson J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Sherman ME; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
Breast ; 66: 272-277, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36375388
ABSTRACT

BACKGROUND:

Few studies have examined detailed features of pregnancy and the postpartum period as potential risk factors for early onset breast cancer (BC) by molecular subtype. These data may have value for improving risk assessment and prevention.

METHODS:

We surveyed parous enrollees in the prospective Mayo Clinic Breast Disease Registry (MCBDR) who had been diagnosed with BC at age <55 years between 2015 and 2020. Summary statistics were used to describe survey responses and reproductive risk factors by BC subtype (defined by estrogen/progesterone receptors and human epidermal growth factor receptor expression, nurse-abstracted from the medical record). Associations were assessed with Kruskal-Wallis and Chi-Square tests, followed by age-adjusted linear and logistic regression models. We compared results from this parous cohort to those from a separate cohort of nulliparous MCBDR participants with BC diagnosed at age <55 years.

RESULTS:

In 436 parous respondents with subtype data abstracted, we identified a higher frequency of BRCA1 mutation, earlier age at diagnosis, and lower BI in patients with triple negative BC. Comparing parous to nulliparous young women with breast cancer, the proportion with TNBC was larger in the latter (12.2% vs. 15.1%, p = 0.03).

CONCLUSIONS:

Early age at diagnosis and deleterious BRCA1 mutation were more frequent among TNBC patients. In addition, parous young women with TNBC had a lower BI than those with other BC subtypes, a hypothesis-generating finding that supports the need for additional research on the cycle of pregnancy-lactation-postpartum involution and BC etiology.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Diseases / Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged / Pregnancy Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Diseases / Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged / Pregnancy Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2022 Document type: Article